Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

SHOPPING: How a daily GLP-1 Activator pill can help curb hunger, reduce brain fog, and improve focus. Thousands of users ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA ...

The new weight-loss tablet was developed in a lab and is based on "a type of β2 agonist." As explained in the news release: ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that’s when a drug is prescribed for something it’s not FDA-approved for.

The new Ozempic? Weight-loss pill Amycretin could be more effective than jabs - Those who took the pill lost around 13 per cent of their body weight over three months ...

Eli Lilly and Company (NYSE:LLY) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 ...

The best way to keep your gut happy is by focusing on a diet rich in a variety of plant-based foods, encouraging healthy ...

Superfoods, nutrient-rich whole foods, offer synergistic health benefits, while supplements provide targeted nutrients for ...